OnKure Therapeutics (OKUR) Analyst & Key Data

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

2

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score4.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$3.10

Median Target+351.61%

$14.00

Potential upside vs current price

DCF Value+36.40%

$4.23

Potential upside vs current price

Current Stock Price

$3.10

Median Target+351.61%

$14.00

Potential upside vs current price

DCF Value+36.40%

$4.23

Potential upside vs current price

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

2

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score4.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$3.10

Median Target+351.61%

$14.00

Potential upside vs current price

DCF Value+36.40%

$4.23

Potential upside vs current price

Current Stock Price

$3.10

Median Target+351.61%

$14.00

Potential upside vs current price

DCF Value+36.40%

$4.23

Potential upside vs current price

OnKure Therapeutics, Inc.